Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3065 - 3072 of 12077 results

Mintz Says No COVID Vaccination, No Office
July 2, 2021| News

Why And How To Link ESG Metrics With Exec Compensation
July 2, 2021| News

Oops: Hundreds of One Medical Patients’ Emails Exposed
July 2, 2021| News

What We’re Reading - July 2, 2021
July 2, 2021| Blog| Viewpoint

Supreme Court Hammers Final Nail in the IP Bridge v. TCL Coffin
July 2, 2021| Blog| Viewpoint

Murky Rules Complicate ADA Compliance Online
July 2, 2021| News

What’s New in 5G - July 2021
July 1, 2021| Blog| Viewpoint
News & Press Releases
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
IP Strategist Daniel Brownstone Joins Mintz in New York
July 30, 2025
Daniel Brownstone has joined Mintz as a Member in the firm’s Intellectual Property Division, adding depth to the firm’s IP Prosecution Practice and contributing to its continued growth in the market. He will be based in the firm’s New York office.
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Events
Let's Talk About: Strengthening San Diego's Venture Ecosystem
The Alexandria Torrey Pines
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
